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ditorialeonatal  hearing-loss  screening  is  on  the  way  to  becoming  systematic
n  FranceThe beneﬁt provided by neonatal hearing-loss screening in
erms of both early diagnosis and effective management of hearing-
mpaired children is now beyond dispute. After more than 15 years
f work-groups under a variety of auspices and experimental cam-
aigns ﬁnanced through Hospital Clinical Research Programs or
y the French National Health Insurance body, 2012 saw a major
dvance in childhood hearing-loss screening in France with the
ublication of the decree of April 23, 2012 concerning the “orga-
ization of newborn hearing screening”.
The decree stipulated that hearing disorder should be explored
ystematically “before discharge from the health facility in which
elivery was managed or to which the infant was  transferred”. It
as also speciﬁed that the newborn hearing-screening program
as to be implemented by the Regional Health Agencies (RHA)
ollowing a national charge-book.
Funding came only set up in 2013, with the Circular
GOS/R1/2013/144 of March 29, 2013 concerning “the 2013 health
acilities budget”, by which the screening program was included
nder diagnosis-related group ﬁnancing: “To this end, 18.70 euros
as been included, in both sectors, in the DRG-based fee for Major
iagnostic Category 15 excluding still-birth, early transfer and
eath”.
The RHA then worked with maternity departments, ENT expert
entres, screening associations and/or perinatal networks, to set
p the organization, region by region. The national charge book
as published in the decree of November 3, 2014 concerning “the
ational charge book for the newborn hearing screening program”,
nd each RHA was to adapt it to its own regional organization.
The basic principle is for hearing to be tested in the maternity
ard by speciﬁcally trained members of staff, using otoacoustic
missions or automated auditory brainstem response, followed
y retesting in the ward in case of doubtful results, AABR being
he technique of choice in neonatology and neonatal intensive
are units. Maternity departments are to be equipped with 1
est apparatus per 1000 deliveries per year; it is vital that this
atio be respected, so as to ensure exhaustiveness of screening. If
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879-7296/© 2015 Elsevier Masson SAS. All rights reserved.hearing was not able to be tested in the maternity department, late
OAE or automated AABR testing may  be performed within 28 days,
either, depending on the regional organization, by the maternity
department, an ENT specialist of the RHA network or designated
hospitals or Early Medico-Social Action Centres (CAMPS). We  need
to stress the requirement that the ENT physicians involved in these
networks should receive ﬁtting payment; negotiations are ongo-
ing with the Health Ministry and national health insurance agency
(CNAMTS), to set the appropriate fee.
The next step is diagnosis, in centres approved by the RHA for
the management of hearing-impaired children.
There are thus a number of steps; but everything is now in place
for a rapid generalization of screening. Pediatric ENT departments
still come across children in whom profound hearing impairment
is not diagnosed before 2 years of age, with consequent psycho-
logical sequelae and impact on communication that may  in some
cases be severe; but the screening program will make this a rarity,
and should raise awareness of childhood hearing disorder in the
medical community as a whole.
The generalization of neonatal hearing loss screening in France
stands as proof that, with sufﬁcient mobilization and tenacity, it
is possible to get a measure implemented: the organization may
be complex, but is fully justiﬁed by the beneﬁt provided to our
patients.
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